Subependymal giant cell astrocytoma historical perspective: Difference between revisions
| Line 9: | Line 9: | ||
*Russell et al was the first scientist to coin the term "subependymal giant cell astrocytoma".<ref name="OuyangZhang2014">{{cite journal|last1=Ouyang|first1=Taohui|last2=Zhang|first2=Na|last3=Benjamin|first3=Thomas|last4=Wang|first4=Long|last5=Jiao|first5=Jiantong|last6=Zhao|first6=Yiqing|last7=Chen|first7=Jian|title=Subependymal giant cell astrocytoma: current concepts, management, and future directions|journal=Child's Nervous System|volume=30|issue=4|year=2014|pages=561–570|issn=0256-7040|doi=10.1007/s00381-014-2383-x}}</ref> | *Russell et al was the first scientist to coin the term "subependymal giant cell astrocytoma".<ref name="OuyangZhang2014">{{cite journal|last1=Ouyang|first1=Taohui|last2=Zhang|first2=Na|last3=Benjamin|first3=Thomas|last4=Wang|first4=Long|last5=Jiao|first5=Jiantong|last6=Zhao|first6=Yiqing|last7=Chen|first7=Jian|title=Subependymal giant cell astrocytoma: current concepts, management, and future directions|journal=Child's Nervous System|volume=30|issue=4|year=2014|pages=561–570|issn=0256-7040|doi=10.1007/s00381-014-2383-x}}</ref> | ||
*Anna et al. was the first to identify that subependymal giant cell astrocytoma demonstrated immunoreactivity for [[neurofilament]], [[GFAP]], [[Substance P|substance P]], and [[Neuron-Specific Enolase (NSE)|neuron-specific enolase]]. | *Anna et al. was the first to identify that subependymal giant cell astrocytoma demonstrated immunoreactivity for [[neurofilament]], [[GFAP]], [[Substance P|substance P]], and [[Neuron-Specific Enolase (NSE)|neuron-specific enolase]]. | ||
*The | *The transformation of a subependymal nodule into a subependymal giant cell astrocytoma was first described by Nabbout. | ||
==References== | ==References== | ||
Revision as of 19:54, 20 November 2015
|
Subependymal giant cell astrocytoma Microchapters |
|
Differentiating Subependymal Giant Cell Astrocytoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Subependymal giant cell astrocytoma historical perspective On the Web |
|
American Roentgen Ray Society Images of Subependymal giant cell astrocytoma historical perspective |
|
FDA on Subependymal giant cell astrocytoma historical perspective |
|
CDC on Subependymal giant cell astrocytoma historical perspective |
|
Subependymal giant cell astrocytoma historical perspective in the news |
|
Blogs on Subependymal giant cell astrocytoma historical perspective |
|
Risk calculators and risk factors for Subependymal giant cell astrocytoma historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]
Overview
Russell et al was the first scientist to coin the term "subependymal giant cell astrocytoma".[1]
Historical Perspective
- Russell et al was the first scientist to coin the term "subependymal giant cell astrocytoma".[1]
- Anna et al. was the first to identify that subependymal giant cell astrocytoma demonstrated immunoreactivity for neurofilament, GFAP, substance P, and neuron-specific enolase.
- The transformation of a subependymal nodule into a subependymal giant cell astrocytoma was first described by Nabbout.